Decisions about initiating and/or continuing antiviral therapy in pregnant women should depend on the stage of the mother\'s liver disease and her potential benefit vs the small risk to the fetus.
详情正文
登录后查看完整内容
使用 DeepEvidence / 梅斯账号登录，新用户可在登录页面注册。
登录 / 注册登录成功后将返回当前页面，继续浏览。